Immatics Accounts Payable from 2010 to 2024

IMTXW Stock  USD 0.50  0.10  25.00%   
Immatics Biotechnologies Accounts Payable yearly trend continues to be fairly stable with very little volatility. Accounts Payable will likely drop to about 4.9 M in 2024. Accounts Payable is the amount immatics biotechnologies GmbH owes to suppliers or vendors for products or services received but not yet paid for. It represents Immatics Biotechnologies' short-term liabilities. View All Fundamentals
 
Accounts Payable  
First Reported
2019-03-31
Previous Quarter
3.8 M
Current Value
8.9 M
Quarterly Volatility
4.3 M
 
Covid
Check Immatics Biotechnologies financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Immatics Biotechnologies' main balance sheet or income statement drivers, such as Tax Provision of 0.0, Net Interest Income of 13.7 M or Interest Income of 14.5 M, as well as many indicators such as Price To Sales Ratio of 13.5, Dividend Yield of 0.0 or PTB Ratio of 3.58. Immatics financial statements analysis is a perfect complement when working with Immatics Biotechnologies Valuation or Volatility modules.
  
Check out the analysis of Immatics Biotechnologies Correlation against competitors.

Latest Immatics Biotechnologies' Accounts Payable Growth Pattern

Below is the plot of the Accounts Payable of immatics biotechnologies GmbH over the last few years. An accounting item on the balance sheet that represents Immatics Biotechnologies obligation to pay off a short-term debt to its creditors. The accounts payable entry is usually reported under current liabilities. If accounts payable of Immatics Biotechnologies are not paid within the agreed terms, the payables are considered to be in default, which may trigger a penalty or interest payment, or the revocation of additional credit from the supplier. Accounts payable may also be considered a source of cash, since they represent funds being borrowed from suppliers. Given these cash flow considerations, suppliers have a natural inclination to push for shorter payment terms, while creditors want to lengthen the payment terms. It is the amount a company owes to suppliers or vendors for products or services received but not yet paid for. It represents the company's short-term liabilities. Immatics Biotechnologies' Accounts Payable historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Immatics Biotechnologies' overall financial position and show how it may be relating to other accounts over time.
Accounts Payable10 Years Trend
Very volatile
   Accounts Payable   
       Timeline  

Immatics Accounts Payable Regression Statistics

Arithmetic Mean4,718,693
Geometric Mean4,594,735
Coefficient Of Variation23.36
Mean Deviation609,077
Median4,866,000
Standard Deviation1,102,451
Sample Variance1.2T
Range5.1M
R-Value(0.03)
Mean Square Error1.3T
R-Squared0.0007
Significance0.93
Slope(6,308)
Total Sum of Squares17T

Immatics Accounts Payable History

20244.9 M
20237.7 M
2022M
2021M
20202.6 M

About Immatics Biotechnologies Financial Statements

Immatics Biotechnologies investors use historical fundamental indicators, such as Immatics Biotechnologies' Accounts Payable, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Immatics Biotechnologies. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Accounts Payable7.7 M4.9 M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Immatics Stock Analysis

When running Immatics Biotechnologies' price analysis, check to measure Immatics Biotechnologies' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Immatics Biotechnologies is operating at the current time. Most of Immatics Biotechnologies' value examination focuses on studying past and present price action to predict the probability of Immatics Biotechnologies' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Immatics Biotechnologies' price. Additionally, you may evaluate how the addition of Immatics Biotechnologies to your portfolios can decrease your overall portfolio volatility.